Search Results

Showing results 1781 - 1790 for weill cornell connect patient portal

Promoter Region as Stem Cell Marker | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/promoter-region-stem-cell-marker

GoTChA: Genotyping of Targeted loci with single-cell Chromatin Accessibility | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/gotcha-genotyping-targeted-loci-single-cell

PHAR 9009 01 Accelerating BioVenture Innovation (ABI) | Enterprise Innovation

... and Events Events Past Events Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell...

https://innovation.weill.cornell.edu/programs-offerings-and-support/courses-and-certificate-programs-innovation-and-entrepreneurship-0

Mixed Reality Image Guidance for Cardiac Interventional Surgery | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/mixed-reality-image-guidance-cardiac-interventional

Low-dose Carbon Monoxide in Treating Metastatic Cancer | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/low-dose-carbon-monoxide-treating-metastatic-cancer

Non-Invasive Delivery of Oncolytic Viruses Using Focused Ultrasound | Enterprise Innovation

.... With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/non-invasive-delivery-oncolytic-viruses-using

Method of Differentiation from Human Pluripotent Stem Cells to Monohormonal Cells | Enterprise Innovation

... and Events Events Past Events Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/method-differentiation-human-pluripotent-stem-cells

Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/discovery-drug-candidates-inhibit-and-eliminate

Nicotinamide Riboside for the Prevention and Treatment of Hearing Loss | Enterprise Innovation

... Past Events Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/nicotinamide-riboside-prevention-and-treatment

Algorithm to Distinguish between Different Tachycardias Caused by Pacemakers/Defibrillators | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/algorithm-distinguish-between-different

Showing results 1781 - 1790 for weill cornell connect patient portal